Because lung cancer screening was shown to be of benefit in 2011 (5) and was approved by CMS in 2015, early-stage resectable (ESR) NSCLC is expected to increase and result in more lung cancer survivors (6). Therefore, assessing the presentation and outcomes of patients undergoing surgery for NSCLC and inter-relationship of ethnicity in regards to marital, economic, histologic, treatment, and insurance variables will be increasingly important.